C12N2770/30011 - CPC Classification

ssRNA viruses positive-sense; Details Nodaviridae

• C12N2770/30021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 2
• C12N2770/30022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 9
• C12N2770/30023 » Virus like particles [VLP] 3
• C12N2770/30031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
• C12N2770/30032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 1
• C12N2770/30033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 0
• C12N2770/30034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 13
• C12N2770/30041 » Use of virus, viral particle or viral elements as a vector 1
• C12N2770/30051 » Methods of production or purification of viral material 2
• C12N2770/30061 » Methods of inactivation or attenuation 0
• C12N2770/30071 » Demonstrated in vivo effect 1
• C12N2770/30088 » For redistribution 0

Recent Application in this class: